FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Cipla USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for amlodipine besylate from Cipla USA Inc., effectively approving a generic formulation of amlodipine besylate.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Stable Angina
• Vasospastic Angina

Drugs mentioned

• Amlodipine besylate (amlodipine besylate)

Snippet

SUPPL AP for AMLODIPINE BESYLATE (AMLODIPINE BESYLATE)